NCT01161056

Brief Summary

The purpose of this study is to enrol generally healthy adults, who are asked to provide a blood sample, to study how the immune system works.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2009

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2009

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

July 9, 2010

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 13, 2010

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
Last Updated

September 10, 2015

Status Verified

September 1, 2015

Enrollment Period

5.9 years

First QC Date

July 9, 2010

Last Update Submit

September 9, 2015

Conditions

Immune System Diseases

Outcome Measures

Primary Outcomes (1)

  • Number of healthy participants enrolled

    This is a registry to enroll healthy individuals who are interested in being contacted about research studies they can participate in as a healthy control

    5 years

Study Arms (1)

Healthy Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Healthy Controls

You may qualify if:

  • Over age 18
  • Generally healthy

You may not qualify if:

  • History of autoimmune disease
  • History of chronic immunodeficiency or chronic viral infections such as Epstein Barr virus, hepatitis or HIV
  • Currently undergoing treatment for cancer
  • Current treatment with immuno-suppressant drugs
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Feinstein Institute for Medical Research

Manhasset, New York, 11030, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

Blood sample will be processed to isolate DNA and peripheral blood mononuclear cells, which will be stored in our Biorepository.

MeSH Terms

Conditions

Immune System Diseases

Study Officials

  • Peter Gregersen, MD

    Northwell Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Center Head

Study Record Dates

First Submitted

July 9, 2010

First Posted

July 13, 2010

Study Start

May 1, 2009

Primary Completion

April 1, 2015

Study Completion

April 1, 2015

Last Updated

September 10, 2015

Record last verified: 2015-09

Locations

US(1)